Table of Contents Author Guidelines Submit a Manuscript
Advances in Chemistry
Volume 2015, Article ID 850974, 8 pages
http://dx.doi.org/10.1155/2015/850974
Research Article

Synthesis, Characterization, and Antihypertensive Evaluation of Some Novel 2,2,8,8-Tetramethyl-2,3,7,8-tetrahydro-4,6-diamino-3,7-dihydroxy-6,7-epoxy-benzo-[1,2-b:5,4-b′]dipyran Derivatives

1Department of Pharmaceutical Chemistry, Krupanidhi College of Pharmacy, Bangalore 35, India
2Department of Pharmaceutical Chemistry, Institute of Pharmacy, Nirma University, Ahmedabad, Gujarat 382481, India

Received 24 June 2014; Accepted 3 January 2015

Academic Editor: Georgia Melagraki

Copyright © 2015 Pankaj Dwivedi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Rudy, “Diversity and ubiquity of K+ channels,” Neuroscience, vol. 25, pp. 729–735, 1988. View at Google Scholar
  2. L. Aguilar-Bryan, C. G. Nichols, S. W. Wechsler et al., “Cloning of the β cell high-affinity sulfonylurea receptor: a regulator of insulin secretion,” Science, vol. 268, no. 5209, pp. 423–426, 1995. View at Publisher · View at Google Scholar · View at Scopus
  3. K. S. Atwal, G. J. Grover, S. Z. Ahmed et al., “Cardioselective anti-ischemic ATP-sensitive potassium channel openers,” Journal of Medicinal Chemistry, vol. 36, no. 24, pp. 3971–3974, 1993. View at Publisher · View at Google Scholar · View at Scopus
  4. F. Dreyer, “Peptide toxins and potassium channels,” Reviews of Physiology Biochemistry and Pharmacology, vol. 115, pp. 93–136, 1990. View at Publisher · View at Google Scholar · View at Scopus
  5. I. Baczkó, I. Leprán, and J. G. Papp, “KATP channel modulators increase survival rate during coronary occlusion-reperfusion in anaesthetized rats,” European Journal of Pharmacology, vol. 324, no. 1, pp. 77–83, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. K. S. Atwal, P. Wang, W. L. Rogers et al., “Small molecule mitochondrial F1F0 ATPase hydrolase inhibitors as cardioprotective agents. Identification of 4-(N-arylimidazole)-substituted benzopyran derivatives as selective hydrolase inhibitors,” Journal of Medicinal Chemistry, vol. 47, no. 5, pp. 1081–1084, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Noma, “ATP-regulated K+ channels in cardiac muscle,” Nature, vol. 305, pp. 147–148, 1983. View at Publisher · View at Google Scholar · View at Scopus
  8. A. D. Wickenden, “K+ channels as therapeutic drug targets,” Pharmacology & Therapeutics, vol. 94, no. 1-2, pp. 157–182, 2002. View at Publisher · View at Google Scholar
  9. S. J. H. Ashcroft and F. M. Ashcroft, “Properties and functions of ATP-sensitive K-channels,” Cellular Signalling, vol. 2, no. 3, pp. 197–214, 1990. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Edwards and A. H. Weston, “The pharmacology of ATP-sensitive potassium channels,” Annual Review of Pharmacology and Toxicology, vol. 33, pp. 597–637, 1993. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Anabuki, M. Hori, H. Ozaki, I. Kato, and H. Karaki, “Mechanisms of pinacidil-induced vasodilatation,” European Journal of Pharmacology, vol. 190, no. 3, pp. 373–379, 1990. View at Publisher · View at Google Scholar · View at Scopus
  12. R. H. Grimm Jr., “Antihypertensive therapy: taking lipids into consideration,” The American Heart Journal, vol. 122, no. 3, pp. 910–918, 1991. View at Publisher · View at Google Scholar · View at Scopus
  13. S. L. Archer, J. Huang, T. Henry, D. Peterson, and E. K. Weir, “A redox-based O2 sensor in rat pulmonary vasculature,” Circulation Research, vol. 73, no. 6, pp. 1100–1112, 1993. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Bellemin-Baurreau, A. Poizot, P. E. Hicks, L. Rochette, and J. Michael Armstrong, “Effects of ATP-dependent K+ channel modulators on an ischemia-reperfusion rabbit isolated heart model with programmed electrical stimulation,” European Journal of Pharmacology, vol. 256, no. 2, pp. 115–124, 1994. View at Publisher · View at Google Scholar · View at Scopus
  15. V. M. Bolotina, “Calcium-activated potassium channels in cultured human endothelial cells are not directly modulated by nitric oxide,” Nature, vol. 368, pp. 850–854, 1994. View at Google Scholar
  16. G. Edwards and A. H. Weston, “The pharmacology of ATP-sensitive potassium channels,” Annual Review of Pharmacology and Toxicology, vol. 33, pp. 597–637, 1993. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Hong, J. Feng, R. Hoen, and G.-Q. Lin, “Synthesis of (±)-3,3′-bis(4-hydroxy-2H-benzopyran): a literature correction,” Tetrahedron, vol. 57, no. 41, pp. 8685–8689, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Tanaka, H. Kawasaki, K. Kurata, Y. Aikawa, Y. Tsukamoto, and T. Inaba, “T-614, a novel antirheumatic drug, inhibits both the activity and induction of cyclooxygenase-2 (COX-2) in cultured fibroblasts,” Japanese Journal of Pharmacology, vol. 67, no. 4, pp. 305–314, 1995. View at Publisher · View at Google Scholar · View at Scopus
  19. E. Tyrrell, K. H. Tesfa, I. Greenwood, and A. Mann, “The synthesis and biological evaluation of a range of novel functionalised benzopyrans as potential potassium channel activators,” Bioorganic and Medicinal Chemistry Letters, vol. 18, no. 3, pp. 1237–1240, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. J. M. Evans, C. S. Fake, T. C. Hamilton, R. H. Poyser, and G. A. Showell, “Synthesis and antihypertensive activity of 6,7-disubstituted trans-4-amino-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-3-ols,” Journal of Medicinal Chemistry, vol. 27, no. 9, pp. 1127–1131, 1984. View at Publisher · View at Google Scholar · View at Scopus
  21. G. C. Rovnyak, S. Z. Ahmed, C. Z. Ding et al., “Cardioselective antiischemic ATP-sensitive potassium channel (KATP) openers. 5. Identification of 4-(N-aryl)-substituted benzopyran derivatives with high selectivity,” Journal of Medicinal Chemistry, vol. 40, no. 1, pp. 24–34, 1997. View at Publisher · View at Google Scholar · View at Scopus
  22. H. H. Herman, S. H. Pollock, L. C. Fowler, and S. W. May, “Demonstration of the potent antihypertensive activity of phenyl-2-aminoethyl sulfides,” Journal of Cardiovascular Pharmacology, vol. 11, no. 5, pp. 201–210, 1988. View at Publisher · View at Google Scholar · View at Scopus
  23. J. L. Wang, K. Aston, D. Limburg et al., “The novel benzopyran class of selective cyclooxygenase-2 inhibitors. Part III: the three microdose candidates,” Bioorganic & Medicinal Chemistry Letters, vol. 20, no. 23, pp. 7164–7168, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. Y.-M. Lee, M.-H. Yen, Y.-Y. Peng et al., “The antihypertensive and cardioprotective effects of (−)-MJ-451, an ATP-sensitive K+ channel opener,” European Journal of Pharmacology, vol. 397, no. 1, pp. 151–160, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. N. Kaur, A. Kaur, Y. Bansal, D. I. Shah, G. Bansal, and M. Singh, “Design, synthesis, and evaluation of 5-sulfamoyl benzimidazole derivatives as novel angiotensin II receptor antagonists,” Bioorganic and Medicinal Chemistry, vol. 16, no. 24, pp. 10210–10215, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Prasanna, E. Manivannan, and S. C. Chaturvedi, “Quantitative structure-activity relationship analysis of a series of 2,3-diaryl benzopyran analogues as novel selective cyclooxygenase-2 inhibitors,” Bioorganic and Medicinal Chemistry Letters, vol. 14, no. 15, pp. 4005–4011, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Bali, Y. Bansal, M. Sugumaran et al., “Design, synthesis, and evaluation of novelly substituted benzimidazole compounds as angiotensin II receptor antagonists,” Bioorganic and Medicinal Chemistry Letters, vol. 15, no. 17, pp. 3962–3965, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. L. Xing, B. C. Hamper, T. R. Fletcher et al., “Structure-based parallel medicinal chemistry approach to improve metabolic stability of benzopyran COX-2 inhibitors,” Bioorganic and Medicinal Chemistry Letters, vol. 21, no. 3, pp. 993–996, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Gierse, M. Nickols, K. Leahy et al., “Evaluation of COX-1/COX-2 selectivity and potency of a new class of COX-2 inhibitors,” European Journal of Pharmacology, vol. 588, no. 1, pp. 93–98, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. H. J. Finlay, J. Lloyd, M. Nyman et al., “Pyrano-[2,3b]-pyridines as potassium channel antagonists,” Bioorganic and Medicinal Chemistry Letters, vol. 18, no. 8, pp. 2714–2718, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. B. Becker, M.-H. Antoine, Q.-A. Nguyen et al., “Synthesis and characterization of a quinolinonic compound activating ATP-sensitive K+ channels in endocrine and smooth muscle tissues,” British Journal of Pharmacology, vol. 134, no. 2, pp. 375–385, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. H. Joo, J. K. Kim, S.-H. Kang et al., “2,3-Diarylbenzopyran derivatives as a novel class of selective cyclooxygenase-2 inhibitors,” Bioorganic and Medicinal Chemistry Letters, vol. 13, no. 3, pp. 413–417, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. R. Hong, J. Feng, R. Hoen, and G.-Q. Lin, “Synthesis of (±)-3,3′-bis(4-hydroxy-2H-benzopyran): a literature correction,” Tetrahedron, vol. 57, no. 41, pp. 8685–8689, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Lim, I.-H. Kim, H. H. Kim, K.-S. Ahn, and H. Han, “Enantioselective syntheses of decursinol angelate and decursin,” Tetrahedron Letters, vol. 42, no. 24, pp. 4001–4003, 2001. View at Publisher · View at Google Scholar · View at Scopus
  35. M. C. Breschi, V. Calderone, A. Martelli et al., “New benzopyran-based openers of the mitochondrial ATP-sensitive potassium channel with potent anti-ischemic properties,” Journal of Medicinal Chemistry, vol. 49, no. 26, pp. 7600–7602, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. T. Takahashi, H. Koga, H. Sato, T. Ishizawa, N. Taka, and J.-I. Imagawa, “Synthesis and vasorelaxant activity of 2-fluoromethylbenzopyran potassium channel openers,” Bioorganic and Medicinal Chemistry, vol. 6, no. 3, pp. 323–337, 1998. View at Publisher · View at Google Scholar · View at Scopus
  37. H. Cho, S. Katoh, S. Sayama et al., “Synthesis and selective coronary vasodilatory activity of 3,4-dihydro- 2,2-bis(methoxymethyl)-2H-1-benzopyran-3-ol derivatives: novel potassium channel openers,” Journal of Medicinal Chemistry, vol. 39, no. 19, pp. 3797–3805, 1996. View at Publisher · View at Google Scholar · View at Scopus
  38. N. Taka, H. Koga, H. Sato, T. Ishizawa, T. Takahashi, and J.-I. Imagawa, “6-Substituted 2,2-bis(fluoromethyl)-benzopyran-4-carboxamide K+ channel openers,” Bioorganic and Medicinal Chemistry, vol. 8, no. 6, pp. 1393–1405, 2000. View at Publisher · View at Google Scholar · View at Scopus
  39. R. Thompson, S. Doggrell, and J. O. Hoberg, “Potassium channel activators based on the benzopyran substructure: synthesis and activity of the C-8 substituent,” Bioorganic & Medicinal Chemistry, vol. 11, no. 8, pp. 1663–1668, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. R. Mannhold, G. Cruciani, H. Weber et al., “6-Substituted benzopyrans as potassium channel activators: synthesis, vasodilator properties, and multivariate analysis,” Journal of Medicinal Chemistry, vol. 42, no. 6, pp. 981–991, 1999. View at Publisher · View at Google Scholar · View at Scopus
  41. J. Renaud, S. F. Bischoff, T. Buhl et al., “Estrogen receptor modulators: identification and structure—activity relationships of potent ERα-selective tetrahydroisoquinoline ligands,” Journal of Medicinal Chemistry, vol. 46, no. 14, pp. 2945–2951, 2003. View at Publisher · View at Google Scholar · View at Scopus